Literature DB >> 9154828

Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs.

P Chaturvedi1, S Sharma, E P Reddy.   

Abstract

The v-src oncogene encodes a nonreceptor tyrosine kinase. When this gene was expressed in the myeloblastic cell line 32Dcl3, it was found to abrogate interleukin-3 (IL-3) dependence of this cell line and to block its ability to terminally differentiate into granulocytes in response to granulocyte colony-stimulating factor (GCSF). In contrast, a highly related tyrosine kinase gene, v-fgr, fails to render this cell line IL-3 independent for growth or to block its ability to undergo terminal differentiation in the presence of GCSF. The active structural domains of v-src that are responsible for the abrogation of IL-3 dependence of myeloid cells and the mechanisms by which v-src transforms these cells are at present unclear. To identify the domains in v-src which are responsible for this activity, we constructed several chimeric recombinants between the v-src and the related Src family member v-fgr by replacing portions of v-src with corresponding domains of v-fgr. These chimeric DNAs were transfected into 32Dcl3 cells and examined for their abilities to render this cell line IL-3 independent. Our results show that only chimeras containing both the SH3 and the SH2 domains of v-src were capable of rendering the 32Dcl3 cell line IL-3 independent. To understand the possible mechanisms underlying the IL-3-independent growth of v-src-transformed 32Dcl3 cells, we examined the phosphorylation status of JAK-1, JAK-2, and JAK-3 kinases in the v-src- and v-fgr-transformed 32Dcl3 cells. Our results show that none of the JAK kinases are constitutively phosphorylated by v-src or v-fgr. We then examined the phosphorylation status of the STAT (signal transducers and activators of transcription) family of transcription factors. Our results show that STAT1, STAT3, and STAT5 exist in a constitutively phosphorylated state in v-src-transformed 32Dcl3 cells, while such constitutive phosphorylation is not seen in v-fgr-transformed cell lines. Our results also show that STAT3 coimmunoprecipitates with v-Src, suggesting that the activation of STAT3 occurs due to direct association with v-Src. However, STAT1 and STAT5, which also exist in a constitutively phosphorylated state in v-src-transformed 32Dcl3 cells, do not coimmunoprecipitate with v-Src, suggesting that these proteins either interact weakly with v-Src or are phosphorylated by a mechanism distinctive from that of STAT3.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154828      PMCID: PMC232182          DOI: 10.1128/MCB.17.6.3295

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

Review 1.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

Authors:  C Schindler; J E Darnell
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

Review 2.  Signaling through the hematopoietic cytokine receptors.

Authors:  J N Ihle; B A Witthuhn; F W Quelle; K Yamamoto; O Silvennoinen
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 3.  Dorsoventral patterning in Drosophila oogenesis.

Authors:  T Schüpbach; S Roth
Journal:  Curr Opin Genet Dev       Date:  1994-08       Impact factor: 5.578

4.  P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation.

Authors:  J Wilson-Rawls; S Xie; J Liu; P Laneuville; R B Arlinghaus
Journal:  Cancer Res       Date:  1996-08-01       Impact factor: 12.701

5.  Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.

Authors:  C L Yu; D J Meyer; G S Campbell; A C Larner; C Carter-Su; J Schwartz; R Jove
Journal:  Science       Date:  1995-07-07       Impact factor: 47.728

6.  Interleukin 2 signaling involves the phosphorylation of Stat proteins.

Authors:  D A Frank; M J Robertson; A Bonni; J Ritz; M E Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway.

Authors:  A Yoshimura; M Ichihara; I Kinjyo; M Moriyama; N G Copeland; D J Gilbert; N A Jenkins; T Hara; A Miyajima
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

8.  Jak-STAT signaling induced by the v-abl oncogene.

Authors:  N N Danial; A Pernis; P B Rothman
Journal:  Science       Date:  1995-09-29       Impact factor: 47.728

9.  Interleukin-3 signals through multiple isoforms of Stat5.

Authors:  M Azam; H Erdjument-Bromage; B L Kreider; M Xia; F Quelle; R Basu; C Saris; P Tempst; J N Ihle; C Schindler
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

10.  Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs.

Authors:  A L Mui; H Wakao; A M O'Farrell; N Harada; A Miyajima
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more
  18 in total

1.  Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.

Authors:  H Chen; J M Lee; Y Zong; M Borowitz; M H Ng; R F Ambinder; S D Hayward
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Regulation of Id gene expression by type I insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor.

Authors:  M Prisco; F Peruzzi; B Belletti; R Baserga
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Stat3 activation by Src induces specific gene regulation and is required for cell transformation.

Authors:  J Turkson; T Bowman; R Garcia; E Caldenhoven; R P De Groot; R Jove
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells.

Authors:  In Ohk Lee; Jie Hyun Kim; Yeun Jung Choi; Michael H Pillinger; Seok-Yong Kim; Martin J Blaser; Yong Chan Lee
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

5.  Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.

Authors:  K Paukku; S Valgeirsdóttir; P Saharinen; M Bergman; C H Heldin; O Silvennoinen
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

6.  Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.

Authors:  Shashidhar S Jatiani; Stacey J Baker; Lewis R Silverman; E Premkumar Reddy
Journal:  Genes Cancer       Date:  2010-10

Review 7.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

8.  BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells.

Authors:  S Ghaffari; H Wu; M Gerlach; Y Han; H F Lodish; G Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

9.  The inducible nitric-oxide synthase (iNOS)/Src axis mediates Toll-like receptor 3 tyrosine 759 phosphorylation and enhances its signal transduction, leading to interferon-β synthesis in macrophages.

Authors:  Ming-Yu Hsieh; Miao Ying Chang; Yen-Jen Chen; Yung Kuo Li; Tsung-Hsien Chuang; Guann-Yi Yu; Chun Hei Antonio Cheung; Hui-Chen Chen; Ming-Chei Maa; Tzeng-Horng Leu
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

Review 10.  Molecular approaches towards the inhibition of the signal transducer and activator of transcription 3 (Stat3) protein.

Authors:  Steven Fletcher; James Turkson; Patrick T Gunning
Journal:  ChemMedChem       Date:  2008-08       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.